The Most Viewed Videos of all Time
Welcome
Login / Register

【談股藺經】藺常念 2020-04-20 港股沒有方向

Play
Mute
00:00
Current Time 0:00
/
Duration Time 3:30
Remaining Time -3:30
Stream TypeLIVE
Loaded: 0%
Progress: 0%
0:00
Fullscreen
Playback Rate
    1
    Subtitles
    • subtitles off
    Captions
    • captions settings
    • captions off
    Chapters
    • Chapters
    auto

      Thanks! Share it with your friends!

      URL

      You disliked this video. Thanks for the feedback!

      Sorry, only registred users can create playlists.
      URL


      Added by Admin in Top 10
      11 Views

      Description

      滙豐從低位反彈

      星期一港股高開,恆生指數升123點,國企指數升不足一點。友邦保險升2.34%,為升幅最大藍籌股,令指數升59點。滙豐升1.77%,令指數升35點。平保升0.76%,令指數數升10點。相反中國移動跌0.75%,令指數跌8點。中海油跌1.07%,令指數跌5點。萬洲跌1.6%,為開市跌幅最大藍籌股。油價下跌,油股弱勢,中石油跌1.09%,中石化跌0.78%。A股開升0.07%,上證綜合指數升2點。開市後港股由升轉跌。滙豐上升,但騰訊,港交所,地產及石油股下跌。旺旺跌2.66%,九倉跌2.4%,新鴻基地產2.1%,為跌幅最大3隻藍籌股。恆生指數最低跌至24225點,跌155點。之後港股反彈,中央銀行把一月貸款利率降0.2%。滙豐領導大市反彈,滙豐升2.15%,令指數升42點。中國移動升1.6%,令指數升17點。中生製藥升3.5%,為升幅最大藍籌股。國美零售引入電商拼多多買入可換股債券,股價升20%。A股上午收市升0.3%,上證綜合指數升8點。恆生指數上午收市升40點,國企指數升51點,成交494億元。

      下午港股窄幅上落,由升轉跌,恆生指數只是微跌幾點。滙豐升1.65%,令指數升32點。中國移動升1.08%,令指數升12點。中國人壽升2.98%,令指#升11點。新鴻基地產跌2.85%,令指數跌11點。物管股及醫藥股領升,中生製藥升3.3%,為升幅最大藍籌股。信達生物科技治膽管癌獲批在美國上升,股價升6.7%。康希諾升6.5%,綠葉製藥升5%,復星醫藥升4%,麗珠藥業升4.7%。平安好醫生升7.7%,阿里健康升4.3%。彩生活升4.8%,中海物業升3.25%,保利物業升3.72%。金山軟件分拆雲業務在美國上升,股價升5.1%。A股收市升0.48%,上證綜合指數升14點。A股收市升0.5%,上證綜合指數升14點。恆生指數收市跌50點,國企指數升9點,成交898億元。

      HSBC rebounded from low level.

      The market opened higher on Monday. Hang Seng index opened up 123 points. H share index rose less than 1 point. AIA rose 2.34% to become the top gainer at opening and contributed 59 point gain. HSBC rose 1.77% for 35 point gain. Ping An r rose 0.76% for 10 point gain. On the contrary, China Mobile lost 0.75% for 8 point loss. CNOOC lost 1.07% for 5 point loss. WH Group lost 1.6% to lead the losers at opening. Crude oil fell. Oil stocks were weak. Petrochina lost 1.09% and Sinopec lost 0.78%. A shares opened up 0.07%. Shanghai composite index rose 2 points. The market turned from gain to loss after opening. The Central Bank lowered the one month loan interest rate by 0.2%. HSBC rose but Tencent, HK Exchanges, oils and local properties fell to depress the market. Wharf lost 2.4% and SHK lost 2.1% to lead the losers. Hang Seng index fell to a morning low of 24225 points, down 155 points. Then the market rebounded on the strength of HSBC which rose 2.15% for 42 point gain. China Mobile rose 1.6% for 17 point gain. Sino Biopharm rose 3.5% to lead the gainers. Gome Retail sold convertible bond to Pinduoduo. Share price soared 20%. A shares closed the morning up 0.3%. Shanghai composite index closed up 8 points. Hang Seng index closed the morning up 40 points. H share index closed up 51 points. Turnover was $49.4 billion.

      The market turned from gain to loss in early afternoon trading. Hang Seng index lost just a few points. HSBC rose 1.65% for 32 point gain. China Mobile rose 1.08% for 12 point gain. China life rose 2.98% for 11 point gain. However, SHK Property lost 2.85% for 11 point loss. Pharmaceutical and property management shares led the market. Sino Biopharm rose 3.3% to lead the blue chips. Innovent Biopharm rose 6.7% as it received permission to sell its bile-duct cancer drug in the US. Cansino rose 6.5%. Luye Pharmaceutical rose 5%. Fosun Pharmaceutical rose 4%. Livzon Pharmaceutical rose 4.7%. PA Good Doctor rose 7.7%. Ali Health rose 4.3%. Colour Life rose 4.8%. CO Property rose 3.25%. Poly Property rose 3.72%. Kingsoft plans to spin off its cloud business to list in the US. Share price rose 5.1%. A shares closed up 0.5%. Shanghai composite index closed up 14 points. Hang Seng index closed down 50 points and H share index closed up 9 points. Turnover was $89.8 billion.
      --------------------------
      請支持「郭思治工作室」,歡迎贊助:
      轉數快FPS: 6677124

      郭思治工作室有限公司
      大新銀行 (040)
      帳號:040-774-15821946

      KWOK SIR WORKSHOP LIMITED
      DAH SING BANK (040)
      Account: 040-774-15821946
      --------------------------

      Show more

      Post your comment

      Comments

      Be the first to comment
      RSS